Index No	International Chemical Identification	EC No	CAS No	Classification		Labelling			Specific Conc. Limits, M-factors	Notes
				Hazard Class and Category Code(s)	Hazard Statement Code(s)	Pictogram, Signal Word Code(s)	Hazard statement Code(s)	Suppl. Hazard statement Code(s)
"009-016-00-2	trisodium hexafluoroaluminate [1]	237-410-6 [1]	13775-53-6 [1]	STOT RE 1 Acute Tox. 4 Aquatic Chronic 2	H372 H332 H411	GHS07 GHS08 GHS09 Dgr	H372 H332 H411
	trisodium hexafluoroaluminate (cryolite) [2]	239-148-8 [2]	15096-52-3 [2]
603-012-00-X	2-ethoxyethanol; ethylene glycol monoethyl ether	203-804-1	110-80-5	Flam. Liq. 3 Repr. 1B Acute Tox. 3 Acute Tox. 4	H226 H360FD H331 H302	GHS02 GHS08 GHS06 Dgr	H226 H360FD H331 H302
603-025-00-0	tetrahydrofuran	203-726-8	109-99-9	Flam. Liq. 2 Carc. 2 Eye Irrit. 2 STOT SE 3	H225 H351 H319 H335	GHS02 GHS07 GHS08 Dgr	H225 H351 H319 H335	EUH019	STOT SE 3; H335: C ≥ 25 % Eye Irrit.2; H319: C ≥ 25 %
613-016-00-3	fuberidazole (ISO); 2-(2-furyl)-1H-benzimidazole	223-404-0	3878-19-1	Carc. 2 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H351 H302 H373 (heart) H317 H400 H410	GHS07 GHS08 GHS09 Wng	H351 H302 H373 (heart) H317 H410		M = 1
617-001-00-2	di-tert-butyl peroxide	203-733-6	110-05-4	Org. Perox. E Flam. Liq. 2 Muta. 2	H242 H225 H341	GHS02 GHS08 Dgr	H242 H225 H341"

Index No	International Chemical Identification	EC No	CAS No	Classification		Labelling			Specific Conc. Limits, M-factors	Notes
				Hazard Class and Category Code(s)	Hazard Statement Code(s)	Pictogram, Signal Word Code(s)	Hazard statement Code(s)	Suppl. Hazard statement Code(s)
‘015-199-00-X	tris[2-chloro-1-chloromethyl)ethyl] phosphate	237-159-2	13674-87-8	Carc. 2	H351	GSH08 Wng	H351
015-200-00-3	indium phosphide	244-959-5	22398-80-7	Carc. 1B Repr. 2 STOT RE 1	H350 H361f H372 (lungs)	GHS08 Dgr	H350 H361f H372 (lungs)		STOT RE 1; H372: C ≥0,1 % Carc 1B; H350: C ≥0,01 % STOT RE 2; H373: 0,01 % ≤ C < 0,1 %
015-201-00-9	trixylyl phosphate	246-677-8	25155-23-1	Repr. 1B	H360F	GHS08 Dgr	H360F
015-202-00-4	tris(nonylphenyl) phosphite	247-759-6	26523-78-4	Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H317 H400 H410	GHS07 GHS09 Wng	H317 H410
015-203-00-X	diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide	278-355-8	75980-60-8	Repr. 2	H361f (causing atrophy of the testes)	GHS08 Wng	H361f (causing atrophy of the testes)
602-109-00-4	Hexabromocyclododecane [1]	247-148-4 [1]	25637-99-4[1]	Repr. 2 Lact.	H361 H362	GHS08 Wng	H361 H362
	1,2,5,6,9,10-hexabromocyclododecane [2]	221-695-9[2]	3194-55-6[2]
606-143-00-0	abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1]	_ [1]	71751-41-2 [1]	Repr. 2 Acute Tox. 2 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1	H361d H300 H330 H372 (nervous system) H400 H410	GHS06 GHS08 GHS09 Dgr	H361d H300 H330 H372 (nervous system) H410		STOT RE 1; H372: C ≥ 5 % STOT RE 2; H373: 0,5 % ≤C<5 % M = 10 000
	avermectin B1a (purity ≥80 %); [2]	265-610-3 [2]	65195-55-3 [2]
606-144-00-6	acequinocyl (ISO); 3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate	—	57960-19-7	Skin Sens. 1 STOT SE 1 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1	H317 H370 (lung) (inhalation) H373 (blood system) H400 H410	GHS07 GHS08 GHS09 Dgr	H317 H370 (lung) (inhalation) H373 (blood system) H410		M = 1 000
607-698-00-1	4-tert-butylbenzoic acid	202-696-3	98-73-7	Repr. 1B STOT RE 1 Acute Tox. 4	H360F H372 H302	GHS07 GHS08 Dgr	H360F H372 H302
612-281-00-2	leucomalachite green; N,N,N',N'-tetramethyl-4,4'-benzylidenedianiline	204-961-9	129-73-7	Carc. 2 Muta. 2	H351 H341	GHS08 Wng	H351 H341
616-205-00-9	Metazachlor (ISO); 2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide	266-583-0	67129-08-2	Skin Sens. 1B Carc. 2 Aquatic Acute 1 Aquatic Chronic 1	H317 H351 H400 H410	GHS07 GHS08 GHS09 Wng	H317 H351 H410		M = 100 M = 100’

Index No	International Chemical Identification	EC No	CAS No	Classification	Labelling	Concentration Limits	Notes
"009-016-00-2	trisodium hexafluoroaluminate [1]	237-410-6 [1]	13775-53-6 [1]	Xn; R20 T; R48/23/25 N; R51-53	T; N R: 20-48/23/25-51/53 S: (1/2-)22-37-45-61
	trisodium hexafluoroaluminate (cryolite) [2]	239-148-8 [2]	15096-52-3 [2]
603-012-00-X	2-ethoxyethanol; ethylene glycol monoethyl ether	203-804-1	110-80-5	R10 Repr. Cat. 2; R60-61 Xn; R20/22	T R: 60-61-10-20/22 S: 53-45		E
603-025-00-0	tetrahydrofuran	203-726-8	109-99-9	F; R11-19 Carc. Cat. 3; R40 Xi; R36/37	F; Xn R: 11-19-40-36/37 S: (2-)(13-)16-29-33-36-37(-46)	Xi; R36/37: C ≥ 25 %
613-016-00-3	fuberidazole (ISO); 2-(2-furyl)-1H-benzimidazole	223-404-0	3878-19-1	Carc. Cat. 3; R40 Xn; R48/22 Xn; R22 Xi; R43 N; R50-53	Xn; N R: 40-48/22-22-43-50/53 S: (2)-22-36/37-60-61	N; R50-53: C ≥ 25 % N; R51-53: 2,5 % ≤ C < 25 % R52-53: 0,25 % ≤ C < 2,5 %
617-001-00-2	di-tert-butyl peroxide	203-733-6	110-05-4	O; R7 F; R11 Muta. Cat. 3, R68	O; F; Xn R: 7-11-68 S: (2-)3/7-14-16-23-36/37/39"

Index No	International Chemical Identification	EC No	CAS No	Classification	Labelling	Concentration Limits	Notes
‘015-199-00-X	tris[2-chloro-1-chloromethyl)ethyl] phosphate	237-159-2	13674-87-8	Carc. Cat. 3; R40	Xn R: 40 S: (2-)36/37
015-200-00-3	indium phosphide	244-959-5	22398-80-7	Carc. Cat. 2; R45 Repr. Cat. 3; R62 T; R48/23	T R: 45–48/23–62 S: 45- 53	T; R48/23: C ≥0,1% Carc Cat 2; R45: C ≥0,01% Xn; R48/20: 0,01%≤ C < 0,1%	E
015-201-00-9	trixylyl phosphate	246-677-8	25155-23-1	Repr. Cat. 2; R60	T R: 60 S: 53-45
015-202-00-4	tris(nonylphenyl) phosphite	247-759-6	26523-78-4	Xi; R43 N; R50-53	Xi; N R: 43-50/53 S: 24-37-60-61
015-203-00-X	diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide	278-355-8	75980-60-8	Repr. Cat. 3; R62	Xn R: 62 S: (2)-22-36/37.
602-109-00-4	Hexabromocyclododecane [1]	247-148-4 [1]	25637-99-4[1]	Repr. Cat. 3; R63 R64	Xn R: 63-64 S: 36/37-53
	1,2,5,6,9,10-hexabromocyclododecane [2]	221-695-9[2]	3194-55-6[2]
606-143-00-0	abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1]	_ [1]	71751-41-2 [1]	Repr. Cat. 3; R63 T+; R26/28 T; R48/23/25 N; R50-53	T+; N R: 63-26/28-48/23/25-50/53 S: 28-36/37-45-60-61	T; R48/23: C ≥ 5% Xn; R48/20: 0,5% ≤ C <5% N; R50-53: C ≥ 0,0025% N; R51-53: 0,00025% ≤ C <0,0025% R52-53: 0,000025% ≤ C<0,00025%
	avermectin B1a (purity ≥80%); [2]	265-610-3 [2]	65195-55-3 [2]
606-144-00-6	acequinocyl (ISO); 3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate	—	57960-19-7	T; R39/23 Xi; R43 N; R50-53	T; N R: 39/23-43-50/53, S: (2-)24-37-38-60-61	N; R50-53: C ≥ 0,025% N; R51-53: 0,0025% ≤ C < 0,025% R52-53: 0,00025% ≤ C < 0,0025%
607-698-00-1	4-tert-butylbenzoic acid	202-696-3	98-73-7	Repr. Cat. 2; R60 T; R48/23/24/25 Xn; R22	T R: 60-22-48/23/24/25 S: 53-45		E
612-281-00-2	leucomalachite green N,N,N',N'-tetramethyl-4,4'-benzylidenedianiline	204-961-9	129-73-7	Carc. Cat. 3; R40 Muta. Cat. 3; R68	Xn R: 40-68 S: (2-)36/37
616-205-00-9	Metazachlor (ISO); 2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide	266-583-0	67129-08-2	R43 Carc. Cat. 3; R40 N; R50-53	Xn; N R: 40-43-50/53 S: (2-)36-37-60-61	N; R50-53: C ≥ 0,25% N; R51-53: 0,025% ≤ C < 0,25% R52-53: 0,0025% ≤ C < 0,025%’